2015 ASCO GU General Views

Abdenour Nabid, MD discusses ABSTRACT 5: Place Of Short-Term Androgen Deprivation Therapy In Intermediate-Risk Prostate Cancer Treated With Radiotherapy: A Phase III Trial

Orlando, FL - GU 2015 - Abdenour Nabid, MD discusses ABSTRACT 5: Place Of Short-Term Androgen Deprivation Therapy In Intermediate-Risk Prostate Cancer Treated With Radiotherapy: A Phase III Trial during Oral Abstract Session: Prostate Cancer at the 2015 Genitourinary Cancers Symposium here today, Thursday February 26, 2015. The conference is the premier meeting on the science and treatment of Genitourinary Cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 2,800 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2015

15GU01253Abdenour NabidMD discusses ABSTRACT 5 Place Of ShortTerm Androgen Deprivatio